LABTVSRDNT• 3 Months (Normalized)
LABT vs RDNT (Lakewood-Amedex Biotherapeutics Inc. vs RadNet Inc.)
Showing Closing Date Range from Jun, 17 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $2.17
-63.83%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
RDNT Performance $77.12
+46.01%
RadNet Inc.
Normalized Baseline0.00%
Alpha Spread Margin RDNT LEADS
-109.84%
RDNT outperforming by 109.84%
LABTRDNT
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT RDNT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | LABT Price | LABT Gain (%) | RDNT Price | RDNT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.17 | -63.83% | $77.12 | +46.01% | -109.84% |
| Sep 14, 2026 | $2.12 | -64.67% | $75.49 | +42.92% | -107.59% |
| Sep 11, 2026 | $2.22 | -63.00% | $75.49 | +42.92% | -105.92% |
| Sep 10, 2026 | $2.05 | -65.83% | $74.28 | +40.63% | -106.46% |
| Sep 09, 2026 | $2.32 | -61.33% | $70.87 | +34.17% | -95.50% |
| Sep 08, 2026 | $2.18 | -63.67% | $71.97 | +36.26% | -99.93% |
| Sep 04, 2026 | $1.88 | -68.67% | $73.71 | +39.55% | -108.22% |
| Sep 03, 2026 | $1.90 | -68.33% | $74.62 | +41.27% | -109.60% |
| Sep 02, 2026 | $2.07 | -65.50% | $75.70 | +43.32% | -108.82% |
| Sep 01, 2026 | $2.76 | -54.00% | $75.52 | +42.98% | -96.98% |
| Aug 31, 2026 | $2.50 | -58.33% | $75.82 | +43.54% | -101.87% |
| Aug 28, 2026 | $2.30 | -61.67% | $74.61 | +41.25% | -102.92% |
| Aug 27, 2026 | $2.49 | -58.50% | $75.36 | +42.67% | -101.17% |
| Aug 26, 2026 | $2.45 | -59.17% | $76.47 | +44.77% | -103.94% |
| Aug 25, 2026 | $2.29 | -61.83% | $76.86 | +45.51% | -107.34% |
Page 1 of 5